New employee-elected board member
21 Oct 2024 //
GLOBENEWSWIRE
Major shareholder announcement
03 Oct 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
16 Sep 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
11 Sep 2024 //
GLOBENEWSWIRE
Major shareholder announcement
10 Sep 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
02 Sep 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
30 Aug 2024 //
GLOBENEWSWIRE
Major shareholder announcement
29 Aug 2024 //
GLOBENEWSWIRE
Novonesis increases outlook for full year 2024
27 Aug 2024 //
GLOBENEWSWIRE
Interim Report H1 2024
27 Aug 2024 //
GLOBENEWSWIRE
Novonesis delivers strong half-year results and increases full-year outlook
27 Aug 2024 //
GLOBENEWSWIRE
Major shareholder announcement
16 Aug 2024 //
GLOBENEWSWIRE
Synamics Therapeutics Attracts Ex-Novozymes Execs As Investors
16 Jul 2024 //
PR NEWSWIRE
Major shareholder announcement
26 Jun 2024 //
GLOBENEWSWIRE
Trading by Management and Close Relations of Management
21 Jun 2024 //
GLOBENEWSWIRE
The era of biosolutions: outlook upgraded for 2024
17 Jun 2024 //
GLOBENEWSWIRE
Incentive Programs For Executive, Leadership Teams And Employees
06 Jun 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
31 May 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
29 May 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
17 May 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
08 May 2024 //
GLOBENEWSWIRE
Trading statement Q1 2024
03 May 2024 //
GLOBENEWSWIRE
Novonesis Q1: 4% Organic Growth, Integration Progress
03 May 2024 //
GLOBENEWSWIRE
Resolutions from the annual shareholders™ meeting 2024
30 Apr 2024 //
GLOBENEWSWIRE
Invitation to the annual shareholders™ meeting
08 Apr 2024 //
GLOBENEWSWIRE
2024 outlook and pro forma financials
21 Mar 2024 //
GLOBENEWSWIRE
Novonesis will host a conference call regarding 2024 outlook & 2023
18 Mar 2024 //
GLOBENEWSWIRE
Novonesis will host a conference call regarding 2024 outlook
18 Mar 2024 //
GLOBENEWSWIRE
Resolutions from the Extraordinary Shareholders Meeting 2024
04 Mar 2024 //
GLOBENEWSWIRE
Invitation to an extraordinary shareholders™ meeting of Novozymes A/S
09 Feb 2024 //
GLOBENEWSWIRE
The Novozymes Report 2023
08 Feb 2024 //
GLOBENEWSWIRE
Settlement of the combination of Novozymes & Chr. Hansen successfully completed
02 Feb 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
02 Feb 2024 //
GLOBENEWSWIRE
Results update for 2023 “ unaudited
01 Feb 2024 //
GLOBENEWSWIRE
Legacy Novozymes delivers solid last full-year results
01 Feb 2024 //
GLOBENEWSWIRE
Total number of voting rights and capital on January 31, 2024
31 Jan 2024 //
GLOBENEWSWIRE
Completion of the combination between Novozymes and Chr. Hansen
29 Jan 2024 //
GLOBENEWSWIRE
The combination of Novozymes and Chr. Hansen is now successfully completed
29 Jan 2024 //
GLOBENEWSWIRE
Major shareholder announcement
29 Jan 2024 //
GLOBENEWSWIRE
Trading by management and close relations of management
29 Jan 2024 //
GLOBENEWSWIRE
All regulatory approvals have been obtained for the combination of Novozymes
26 Jan 2024 //
GLOBENEWSWIRE
Update on merger approval process for the combination of Novozymes & Chr. Hansen
20 Dec 2023 //
GLOBENEWSWIRE
New year, new name for Pipeline, Novozymes and Chr. Hansen
15 Dec 2023 //
FIERCE PHARMA
Novozymes™ updated financial calendar
13 Dec 2023 //
GLOBENEWSWIRE
Update on the merger process for the combination of Novozymes and Chr. Hansen
12 Dec 2023 //
GLOBENEWSWIRE
Trading by management and close relations of management
24 Nov 2023 //
GLOBENEWSWIRE
Update on merger EC offered remedy proposal
20 Nov 2023 //
GLOBENEWSWIRE
Update on the merger approval process for combination of Novozymes & Chr. Hansen
20 Nov 2023 //
GLOBENEWSWIRE
Novozymes launches Quara® LowP for renewable diesel feedstock pre-treatment
09 Nov 2023 //
GLOBENEWSWIRE
Trading by management and close relations of management
30 Oct 2023 //
GLOBENEWSWIRE
Novozymes accelerates growth in Q3
26 Oct 2023 //
GLOBENEWSWIRE
Interim dividend payment
12 Oct 2023 //
GLOBENEWSWIRE
Novozymes launches new biosolution to redefine the plant-based meat experience
28 Sep 2023 //
GLOBENEWSWIRE
Novozymes & Bactolife join forces to significantly reduce post weaning diarrhea
04 Sep 2023 //
GLOBENEWSWIRE
Update on the combination of Novozymes and Chr. Hansen
04 Sep 2023 //
GLOBENEWSWIRE
Trading by management and close relations of management
15 Aug 2023 //
GLOBENEWSWIRE
Interim report for 1H 2023
09 Aug 2023 //
GLOBENEWSWIRE
Novozymes delivers results within expectations in the first half of 2023
09 Aug 2023 //
GLOBENEWSWIRE
Change to the Executive Leadership Team
04 May 2023 //
GLOBENEWSWIRE
Interim report for Q1 2023
26 Apr 2023 //
GLOBENEWSWIRE